Respiratory Devices Global Market - Forecast to 2029

Publishing Date : June, 2023
Report Code : HCMD 0128
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Note: The report would be dispatched after confirmation of payment

Respiratory disease is the diseases and disorders of the airways and the lungs that affect human respiration. Respiratory diseases such as asthma, chronic obstructive pulmonary diseases (COPD), sleep apnea and others may be caused by infection, by smoking tobacco, or by breathing in second hand tobacco smoke, radon, asbestos, or other forms of air pollution. Respiratory care device are used for the diagnosis, treatment and monitoring of Respiratory diseases. These devices help patients in need of support for breathing, removal of carbon dioxide, and therapy to reduce disuse atrophy of abdominal wall muscles. Technological advancements in respiratory care devices and funding for the development of innovative respiratory technologies further boost the growth of market.

According to IQ4I analysis, the respiratory care devices global market is estimated is expected to grow at a mid single digit CAGR from 2022 to 2029 to reach $24,866.6 million by 2029. The market is being propelled by several factors, including the rising incidence and prevalence of respiratory diseases like Asthma, COPD, and others. The growing elderly population and the subsequent rise in the occurrence of respiratory disorders also contribute to the market's growth. Whereas rising use of non – invasive respiratory care devices, advancements in respiratory care devices, funding for the development of innovative respiratory care technologies and favorable reimbursement are providing immense opportunities to the market. However, product recalls, adverse effects associated with some of the respiratory care devices, availability of alternative respiratory care devices and stringent regulations are hampering the growth of the market.

The respiratory care devices market is segmented based on the product, application, end – user and geography. Based on the product, the respiratory care devices market is segmented as diagnostic, therapeutic, monitoring devices, and consumables. Among these, therapeutic devices market commanded the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029.  The therapeutic devices market is sub – segmented into Humidifier, Nebulizers, Oxygen concentrators, PAP devices, Resuscitators, Ventilators, Inhalers, Neuromodulation devices and Airway Clarence devices & others. Among these, PAP devices global market accounted for the largest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2029. Neuromodulation devices market is expected to grow at a high double digit CAGR from 2022 to 2029.

Humidifier global market is further classified into Active Humidifiers and Passive Humidifiers. Among these, Active Humidifiers accounted for the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. Nebulizer’s global market is segmented into Jet Nebulizer, Ultrasonic Nebulizer, Mesh Nebulizer and Smart Nebulizers. Among these, Jet Nebulizer is accounted for the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Smart Nebulizers is expected to grow at a mid single digit CAGR from 2022 to 2029. Oxygen Concentrators global market is segmented into Stationary Oxygen Concentrators and Portable Oxygen Concentrators. Among these, Portable Oxygen Concentrators is accounted for the largest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2029. Positive Airway Pressure Devices (PAP) Global Market is segmented into Continuous PAP Devices (CPAP), Automatic PAP (APAP) Devices and Bi-Level PAP (BPAP) Devices. Among these, Automatic PAP (APAP) Devices market accounted for the largest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2029. Resuscitators global market is segmented into Manual Resuscitator and Gas Powdered Resuscitator. Among these, Manual Resuscitator accounted for the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. Ventilators global market is segmented into ICU Ventilator, Emergency and Transport Ventilator and Others. Among these, Emergency and Transport Ventilator global market is accounted for the largest revenue of in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Inhalers global market is segmented into Dry Powder Inhalers, Metered Dose Inhalers and Soft Mist Inhalers. Among these, Metered Dose Inhalers accounted for the largest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2029. Soft Mist Inhaler is expected to grow at a mid teen CAGR from 2022 to 2029.

Monitoring devices global market is segmented Pulse Oximeters, Capnographs and Gas analyzers and others. Among these, Pulse Oximeters accounted for the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. Capnographs is expected to grow at a low single digit CAGR from 2022 to 2029. Pulse Oximeters global market is segmented into Finger Pulse Oximeters, Handheld Pulse Oximeters, Tabletop Pulse Oximeters and Others. Among these, Handheld Pulse Oximeters accounted for the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. Finger Pulse Oximeters is expected to grow at a low single digit CAGR from 2022 to 2029. Diagnostic device segment is further classified into Spirometers, Peak flow meter, Polysomnograph devices, Respiratory polygraph and others. Among these, Spirometers accounted for the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. Polysomnograph devices are expected to grow at a mid single digit CAGR from 2022 to 2029. Spirometers segment is further classified into Volumetric Spirometers and Flow Measuring Spirometers. Among these, Flow Measuring Spirometers is accounted for the largest revenue of in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Polysomnograph devices segmented into Clinical Polysomnograph Devices and Ambulatory Polysomnographs Devices. Among these, Clinical Polysomnograph Devices accounted for the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Consumables global market is classified into Masks, Air Management appliances, Nasal cannula, Filters and Others Consumables. Among these, Masks accounted for the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029.

The respiratory care devices market based on application is segmented into obstructive, restrictive, vascular, infectious and other respiratory conditions. Among applications, obstructive respiratory conditions commanded the largest revenue in 2022. The market is expected to grow at a mid single digit CAGR from 2022 to 2029. The obstructive respiratory conditions are further segmented into COPD (chronic bronchitis and emphysema), asthma, cystic fibrosis, and obstructive sleep apnea, among these; Obstructive Sleep Apnea commanded the largest share in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2029. COPD market is further segmented into Chronic Bronchitis and Emphysema. Among these, Chronic Bronchitis global market is accounted for the highest revenue in 2022 and is expected to grow at high single digit CAGR from 2022 to 2029. Restrictive respiratory condition is further segmented into ARDS and Restrictive Lung Diseases and others. Among these, ARDS segment accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Vascular Diseases is further classified into Pulmonary Fibrosis, Pulmonary Edema and Pulmonary Hypertension. Among these, Pulmonary Edema accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Pulmonary Fibrosis is expected to grow at a mid single digit CAGR from 2022 to 2029. Infectious respiratory condition is further segmented into Pneumonia, Tuberculosis and COVID-19. Among these, Pneumonia sub – segment is accounted for the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Tuberculosis is expected to grow at a high single digit CAGR from 2022 to 2029.

The end-users market is segmented into hospitals, home care and ambulatory surgical centers, among them, hospital care settings commanded the largest revenue in 2022. The market is expected to grow at a mid single digit CAGR from 2022 to 2029. The Homecare setting is expected to grow at a high single digit CAGR from 2022 to 2029. Respiratory home healthcare has opened new opportunities for the respiratory care devices market. The hospital end-user segment is further sub-segmented based on care settings into emergency care, critical care/ICU, acute care, sleep center and others. The critical care segment commanded the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. The sleep centers are expected to grow at mid single digit CAGR from 2022 to 2029.

The geographic market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Among these, North-America commanded the largest revenue in 2022. The market is expected to grow at a mid single digit CAGR from 2022 to 2029. The factors such as increasing healthcare expenditure, rising prevalence of respiratory disorders, increasing aging population, favorable reimbursement policies, government initiatives focus on promoting research, development, and access to innovative respiratory care technologies (For instance, Asthma and Allergy Foundation of America (AAFA) dedicated to saving lives and reducing the burden of disease for people with asthma and allergies through support, advocacy, education, and research), launch of advanced respiratory care devices by the companies, acquisition of respiratory care based companies to expand their market reach and receiving funding to develop advanced respiratory care products are driving the North America respiratory care devices market.

Asia-Pacific is expected to grow at a high single digit CAGR from 2022 to 2029. Asia-Pacific tends to be fastest-growing segment due to increasing healthcare expenditure, increasing incidence and prevalence of respiratory disease, increasing in aging population, high acceptance of technological advancements, government initiatives to increase awareness by education campaigns and development of advanced affordable and low cost respiratory products.

The major companies in Respiratory care devices are Medtronic (Ireland), Getinge Groups (Maquet GmbH) (Sweden), Vyaire Medical, Inc (U.S.), Resmed Inc (U.S.), Philips N.V. (TheNetherlands), Fisher and Paykel healthcare (New Zealand), Dragerwerk AG & Co. KGaA (Germany), Air Liquide S.A (France), Masimo (U.S.) and Inspire Medical (U.S.)

TABLE OF CONTENTS

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     REPORT SCOPE
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET CRACKDOWN AND DATATRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
  • 3     MARKET OVERVIEW
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
    • 3.4     MARKET DYNAMICS
      • 3.4.1     DRIVERS AND OPPORTUNITIES
        • 3.4.1.1     Rising incidences of respiratory diseases such as copd, asthma, and sleep apnea, which has resulted in a higher demand for respiratory care devices
        • 3.4.1.2     Growing geriatric population and the consequent increase in the incidence of respiratory disorders among them, creating a substantial demand for respiratory care devices
        • 3.4.1.3     Rising use of non-invasive respiratory care devices
        • 3.4.1.4     Advancements in respiratory care devices and funding for the development of innovative respiratory care technologies
        • 3.4.1.5     Favorable reimbursement scenario
      • 3.4.2     RESTRAINTS AND THREATS
        • 3.4.2.1     Product recalls
        • 3.4.2.2     Harmful side effects associated with the use of certain respiratory care devices
        • 3.4.2.3     Availability of low-cost products from local manufacturers
        • 3.4.2.4     Availability of alternatives treatments such as medication and surgery
        • 3.4.2.5     Stringent regulatory policies
    • 3.5     REGULATORY AFFAIRS
      • 3.5.1     U.S.
      • 3.5.2     EUROPE
      • 3.5.3     INDIA
      • 3.5.4     CHINA
      • 3.5.5     JAPAN
      • 3.5.6     ISO STANDARDS
    • 3.6     PORTER’S FIVE FORCE ANALYSIS
      • 3.6.1     THREAT OF NEW ENTRANTS
      • 3.6.2     THREAT OF SUBSTITUTES
      • 3.6.3     COMPETITIVE RIVALRY
      • 3.6.4     BARGAINING POWER OF SUPPLIERS
      • 3.6.5     BARGAINING POWER OF BUYERS
    • 3.7     SUPPLY CHAIN ANALYSIS
    • 3.8     MARKET SHARE ANALYSIS
      • 3.8.1     RESPIRATORY CARE DEVICES GLOBAL MARKET SHARE
      • 3.8.2     VENTILATOR GLOBAL MARKET SHARE ANALYSIS
      • 3.8.3     PAP GLOBAL MARKET SHARE ANALYSIS
      • 3.8.4     CPAP GLOBAL MARKET SHARE ANALYSIS
      • 3.8.5     APAP GLOBAL MARKET SHARE ANALYSIS
      • 3.8.6     BPAP GLOBAL MARKET SHARE ANALYSIS
    • 3.9     REIMBURSEMENT SCENARIO
    • 3.1     TECHNOLOGICAL ADVANCEMENTS
      • 3.10.1     INTEGRATED DEVICES
      • 3.10.2     NON – INVASIVE NANOSENSOR BASED WEARBLE RESPIRATORY MONITORING
      • 3.10.3     AI BASED RESPIRATORY MONITORING
      • 3.10.4     HIGH VELOCITY THERAPY
      • 3.10.5     DIGITAL TECHNOLOGIES IN RESPIRATORY DEVICES
      • 3.10.6     ADVANCED NEONATAL RESPIRATORY SOLUTIONS
        • 3.10.6.1     Neonatal lung monitoring
        • 3.10.6.2     Neovent
      • 3.10.7     SELF - CARE RESPIRATORY MONITOR
    • 3.11     FUNDING SCENARIO
    • 3.12     CLINICAL TRIALS
  • 4     RESPIRATORY CARE DEVICES GLOBAL MARKET, BASED ON PRODUCTS
    • 4.1     INTRODUCTION
    • 4.2     THERAPEUTIC RESPIRATORY CARE DEVICES
      • 4.2.1     HUMIDIFIERS
        • 4.2.1.1     Active humidifiers
        • 4.2.1.2     Passive humidifiers
      • 4.2.2     NEBULIZERS
        • 4.2.2.1     Jet nebulizers
        • 4.2.2.2     Ultrasonic nebulizers
        • 4.2.2.3     Mesh nebulizers
        • 4.2.2.4     Smart nebulizers
      • 4.2.3     OXYGEN CONCENTRATORS
        • 4.2.3.1     Stationary oxygen concentrators
        • 4.2.3.2     Portable oxygen concentrators
      • 4.2.4     POSITIVE AIRWAY PRESSURE DEVICES (PAP)
        • 4.2.4.1     Continuous pap devices (CPAP)
        • 4.2.4.2     Automatic pap (APAP) devices
        • 4.2.4.3     Bbi-level pap (BPAP) devices
      • 4.2.5     RESUSCITATORS
        • 4.2.5.1     Manual resuscitators
        • 4.2.5.2     Gas powered resuscitators
      • 4.2.6     VENTILATORS
      • 4.2.7     VENTILATORs MARKET BASED ON TYPE
        • 4.2.7.1     ICU ventilators
        • 4.2.7.2     Emergency and transport ventilators
        • 4.2.7.3     Others
      • 4.2.8     VENTILATORs MARKET BASED ON END-USERS
      • 4.2.9     INHALERS
        • 4.2.9.1     Dry powder inhalers
        • 4.2.9.2     Metered dose inhalers
        • 4.2.9.3     Soft mist inhalers
      • 4.2.10     NEUROMODULATION DEVICES
      • 4.2.11     AIRWAY CLEARANCE DEVICES AND OTHERS
    • 4.3     MONITORING RESPIRATORY CARE DEVICES
      • 4.3.1     PULSE OXIMETERS
        • 4.3.1.1     Finger pulse oximeters
        • 4.3.1.2     Handheld pulse oximeters
        • 4.3.1.3     Tabletop pulse oximeters
        • 4.3.1.4     Others
      • 4.3.2     CAPNOGRAPHS
      • 4.3.3     GAS ANALYZERS AND OTHERS
    • 4.4     DIAGNOSTIC RESPIRATORY CARE DEVICES
      • 4.4.1     SPIROMETERS
        • 4.4.1.1     Volumetric spirometers
        • 4.4.1.2     Flow measuring spirometers
      • 4.4.2     PEAK FLOW METERS
      • 4.4.3     POLYSOMNOGRAPH DEVICES (PSG)
        • 4.4.3.1     Clinical polysomnography devices
        • 4.4.3.2     Ambulatory polysomnography devices
      • 4.4.4     RESPIRATORY POLYGRAPH
      • 4.4.5     OTHER DIAGNOSTIC DEVICES
    • 4.5     CONSUMABLES
      • 4.5.1     MASKS
        • 4.5.1.1     Full face masks
        • 4.5.1.2     Nasal masks
        • 4.5.1.3     Nasal pillow masks
        • 4.5.1.4     Other masks
      • 4.5.2     AIRWAY MANAGNEMNT APPLIENCES
      • 4.5.3     NASAL CANNULAS
      • 4.5.4     FILTERS
      • 4.5.5     OTHER CONSUMABLES
  • 5     RESPIRATORY CARE DEVICES GLOBAL MARKET, BASED ON

APPLICATION

    • 5.1     INTRODUCTION
    • 5.2     OBSTRUCTIVE RESPIRATORY CONDITION
      • 5.2.1     CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
        • 5.2.1.1     Chronic bronchitis
        • 5.2.1.2     Emphysema
      • 5.2.2     ASTHMA
      • 5.2.3     CYSTIC FIBROSIS
      • 5.2.4     OBSTRUCTIVE SLEEP APNEA (OSA)
    • 5.3     RESTRICTIVE RESPIRATORY CONDITION
      • 5.3.1     ARDS
      • 5.3.2     RESTRECTIVE LUNG DISEASES AND OTHERS
    • 5.4     VASCULAR DISEASES
      • 5.4.1     PULMONARY FIBROSIS
      • 5.4.2     PULMONARY EDEMA
      • 5.4.3     PULMONARY HYPERTENSION (PH)
    • 5.5     INFECTIOUS RESPIRATORY CONDITION
      • 5.5.1     PNEUMONIA
      • 5.5.2     TUBERCULOSIS
      • 5.5.3     COVID - 19
    • 5.6     OTHERS
  • 6     RESPIRATORY CARE DEVICES GLOBAL MARKETY, BASED ON END-USERS
    • 6.1     INTRODUCTION
    • 6.2     HOSPITALS
      • 6.2.1     EMERGENCY CARE
      • 6.2.2     CRITICAL CARE/INTENSIVE CARE UNIT (ICU)
      • 6.2.3     ACUTE CARE
      • 6.2.4     SLEEP CENTER UNIT
      • 6.2.5     OTHER HOSPITAL CARE SETTINGS (OPD)
    • 6.3     HOME HEALTH CARE
    • 6.4     AMBULATORY SURGICAL CENTERS
  • 7     REGIONAL MARKET ANALYSIS
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     UNITED STATES (U.S.)
      • 7.2.2     REST OF NORTH AMERICA
    • 7.3     EUROPE
      • 7.3.1     GERMANY
      • 7.3.2     ITALY
      • 7.3.3     FRANCE
      • 7.3.4     REST OF EUROPE
    • 7.4     ASIA-PACIFIC
      • 7.4.1     JAPAN
      • 7.4.2     CHINA
      • 7.4.3     INDIA
      • 7.4.4     REST OF APAC
    • 7.5     REST OF THE WORLD
      • 7.5.1     BRAZIL
      • 7.5.2     REST OF LATIN AMERICA
      • 7.5.3     MIDDLE EAST AND OTHER COUNTRIES
  • 8     COMPANY DEVELOPMENTS
    • 8.1     INTRODUCTION
    • 8.2     NEW PRODUCT LAUNCHES
    • 8.3     APPROVALS
    • 8.4     AGREEMENT
    • 8.5     EXPANSION
  • 9     MAJOR COMPANIES
    • 9.1     AIR LIQUIDE S.A
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     PRODUCT PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     DRAGERWERK AG & CO. KGAA
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     PRODUCT PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     FISHER AND PAYKEL HEALTHCARE CORPORATION LIMITED
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     PRODUCT PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     INSPIRE MEDICAL SYSTEM, INC.
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS
      • 9.4.3     PRODUCT PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     GETINGE GROUPS
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     PRODUCT PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY
      • 9.5.6     SWOT ANALYSIS
    • 9.6     MASIMO CORPORATION
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     PRODUCT PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     MEDTRONIC, PLC
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     PRODUCT PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUSINESS STRATEGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     PHILIPS N.V.
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     PRODUCT PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     RESMED INC.
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     PRODUCT PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.1     VYAIRE MEDICAL, INC.
      • 9.10.1     OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     PRODUCT PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 2     RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BASED PRODUCTS (2021-2029) ($MN)
      • TABLE 3     THERAPEUTIC RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 4     THERAPEUTIC RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 5     HUMIDIFIERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 6     HUMIDIFIERS GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 7     ACTIVE HUMIDIFIERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 8     PASSIVE HUMIDIFIERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 9     NEBULIZERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 10     NEBULIZERS GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 11     JET NEBULIZERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 12     ULTRASONIC NEBULIZER GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 13     MESH NEBULIZERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 14     SMART NEBULIZERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 15     OXYGEN CONCENTRATORS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 16     OXYGEN CONCENTRATORS GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 17     STATIONARY OXYGEN CONCENTRATORS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 18     PORTABLE OXYGEN CONCENTRATORS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 19     POSITIVE AIRWAY PRESSURE DEVICES GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 20     POSITIVE AIRWAY PRESSURE DEVICES GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 21     CONTINUOUS PAP DEVICES (CPAP) GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 22     AUTOMATIC PAP (APAP) DEVICES GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 23     BI-LEVEL PAP (BPAP) DEVICES GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 24     RESUSCITATORS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 25     RESUSCITATORS GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 26     MANUAL RESUSCITATOR GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 27     GAS POWERED RESUSCITATOR GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 28     VENTILATORS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 29     VENTILATORS GLOBAL MARKET REVENUE, BASED ON TYPE, (2021-2029) ($MN)
      • TABLE 30     ICU VENTILATORS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 31     EMERGENCY AND TRANSPORT VENTILATORS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 32     OTHERS VENTILATORS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 33     VENTILATORS GLOBAL MARKET REVENUE, BASED ON END-USERS, (2021-2029) ($MN)
      • TABLE 34     EMERGENCY CARE VENTILATORS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 35     CRITICAL CARE VENTILATORS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 36     ACUTE CARE VENTILATORS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 37     AMBULATORY VENTILATORS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 38     HOMECARE VENTILATORS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 39     INHALERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 40     INHALERS GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 41     DRY POWDER INHALERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 42     METERED DOSE INHALERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 43     SOFT MIST INHALER DEVICES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 44     NEUROMODULATION DEVICES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 45     AIRWAY CLEARANCE DEVICES AND OTHERSGLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 46     MONITORING RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 47     MONITORING RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 48     PULSE OXIMETERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 49     PULSE OXIMETERS GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 50     FINGER PULSE OXIMETERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 51     HANDHELD PULSE OXIMETERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 52     TABLETOP PULSE OXIMETERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 53     OTHER PULSE OXIMETERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 54     CAPNOGRAPHS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 55     GAS ANALYZERS AND OTHERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 56     DIAGNOSTIC RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 57     DIAGNOSTIC RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 58     SPIROMETERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 59     SPIROMETERS GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 60     VOLUMETRIC SPIROMETERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 61     FLOW MEASURING SPIROMETERS GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 62     PEAK FLOW METER GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • TABLE 63     POLYSOMNOGRAPH DEVICES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 64     POLYSOMNOGRAPH DEVICES GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 65     CLINICAL POLYSOMNOGRAPH DEVICES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 66     AMBULATORY POLYSOMNOGRAPHS DEVICES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 67     RESPIRATORY POLYGRAPH GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 68     OTHER DIAGNOSTIC DEVICES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 69     CONSUMABLES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 70     CONSUMABLES GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 71     MASKS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 72     MASKS GLOBAL MARKET REVENUE, BASED ON PRODUCT, (2021-2029) ($MN)
      • TABLE 73     FUL FACE MASKS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 74     NASAL MASKS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 75     NASAL PILLOW MASKS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 76     OTHER MASKS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 77     AIR MANAGNMENT APPLIANCES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 78     NASAL CANNULAS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 79     FILTERS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 80     OTHER CONSUMABLES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 81     RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 82     OBSTRUCTIVE RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 83     OBSTRUCTIVE RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 84     COPD GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 85     COPD GLOBAL MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029)($MN)
      • TABLE 86     CHRONIC BRONCHITIS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 87     EMPHYSEMA GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 88     ASTHMA GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 89     CYSTIC FIBROSIS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 90     OBSTRUCTIVE SLEEP APNEA GLOBAL MARKET REVENUE, BASED ON THE REGION, (2021-2029) ($MN)
      • TABLE 91     RESTRICTIVE RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 92     RESTRICTIVE RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 93     ARDS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 94     RESTRICTIVE LUNG DISEASES AND OTHERS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 95     VASCULAR DISEASES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 96     VASCULAR DISEASES GLOBAL MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 97     PULMONARY FIBROSIS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 98     PULMONARY EDEMA GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 99     PULMONARY HYPERTENSION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 100     INFECTIOUS RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 101     INFECTIOUS RESPIRATORY CONDITION GLOBAL MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 102     PNEUMONIA GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 103     TUBERCULOSIS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 104     COVID – 19 GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 105     OTHER RESPIRATORY APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 106     RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BASED ON END-USER, (2021-2029) ($MN)
      • TABLE 107     HOSPITALS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 108     HOSPITALS GLOBAL MARKET REVENUE, BASED ON CARE SETTING, (2021-2029) ($MN)
      • TABLE 109     EMERGENCY CARE GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 110     CRITICAL CARE/ICU GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 111     ACUTE CARE GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 112     SLEEP CENTER GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 113     OTHER HOSPITAL CARE SETTINGS GLOBAL MARKET REVENUE, BASED REGION, (2021-2029) ($MN)
      • TABLE 114     HOME CARE GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 115     AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 116     RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 117     NORTH AMERICA RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCT, (2021-2029) ($MN)
      • TABLE 118     NORTH AMERICA THERAPEUTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCT, (2021-2029) ($MN)
      • TABLE 119     NORTH AMERICA HUMIDIFIERS MARKET REVENUE, BASED ON PRODUCT, (2021-2029) ($MN)
      • TABLE 120     NORTH AMERICA NEBULIZERS MARKET REVENUE, BASED ON PRODUCT, (2021-2029) ($MN)
      • TABLE 121     NORTH AMERICA OXYGEN CONCENTRATORS MARKET REVENUE, BASED ON PRODUCT, (2021-2029) ($MN)
      • TABLE 122     NORTH AMERICA POSITIVE AIRWAY PRESSURE DEVICES MARKET REVENUE, BASED ON PRODUCT, (2021-2029) ($MN)
      • TABLE 123     NORTH AMERICA RESUSCITATORS MARKET REVENUE, BASED ON PRODUCT, (2021-2029) ($MN)
      • TABLE 124     NORTH AMERICA VENTILATORS DEVICE MARKET REVENUE, BASED ON TYPE, (2021-2029) ($MN)
      • TABLE 125     NORTH AMERICA VENTILATORS MARKET REVENUE, BASED ON END-USER, (2021-2029) ($MN)
      • TABLE 126     NORTH AMERICA INHALERS MARKET REVENUE, BASED ON PRODUCT, (20221-2029) ($MN)
      • TABLE 127     NORTH AMERICA MONITORING RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCT, (2021-2029) ($MN)
      • TABLE 128     NORTH AMERICA PULSE OXIMETER MARKET REVENUE, BASED ON PRODUCT, (2021-2029) ($MN)
      • TABLE 129     NORTH AMERICA DIAGNOSTIC RESPRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCT, (2021-2029) ($MN)
      • TABLE 130     NORTH AMERICA SPIROMETERS MARKET REVENUE, BASED ON PRODUCT, (2021-2029) ($MN)
      • TABLE 131     NORTH AMERICA POLYSOMNOGRAPH DEVICES MARKET REVENUE, BASED ON PRODUCT, (2021-2029) ($MN)
      • TABLE 132     NORTH AMERICA CONSUMABLES MARKET REVENUE, BASED ON PRODUCT, (2021-2029) ($MN)
      • TABLE 133     NORTH AMERICA MASKS MARKET REVENUE, BASED ON PRODUCT, (2021-2029) ($MN)
      • TABLE 134     NORTH AMERICA RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 135     NORTH AMERICA OBSTRUCTIVE RESPIRATORY CONDITION MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 136     NORTH AMERICA COPD MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 137     NORTH AMERICA RESTRICTIVE RESPIRATORY CONDITION MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 138     NORTH AMERICA VASCULAR DISEASES MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 139     NORTH AMERICA INFECTIOUS RESPIRATORY CONDITION MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 140     NORTH AMERICA RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON END-USER, (2021-2029) ($MN)
      • TABLE 141     NORTH AMERICA HOSPITAL MARKET REVENUE, BASED ON CARE SETTINGS, (2021-2029) ($MN)
      • TABLE 142     NORTH AMERICA RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON COUNTRY, (2021-2029) ($MN)
      • TABLE 143     EUROPE RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 144     EUROPE THERAPEUTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 145     EUROPE HUMIDIFIERS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 146     EUROPE NEBULIZERS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 147     EUROPE OXYGEN CONCENTRATORS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 148     EUROPE POSITIVE AIRWAY PRESSURE (PAP) MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 149     EUROPE RESUSCITATORS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 150     EUROPE VENTILATORS DEVICES MARKET REVENUE, BASED ON TYPE, (2021-2029) ($MN)
      • TABLE 151     EUROPE VENTILATORS MARKET REVENUE, BASED ON END-USERS, (2021-2029) ($MN)
      • TABLE 152     EUROPE INHALERS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 153     EUROPE MONITORING RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 154     EUROPE PULSE OXIMETER MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 155     EUROPE DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCT, (2021-2020) ($MN)
      • TABLE 156     EUROPE SPIROMETERS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 157     EUROPE POLYSOMNOGRAPH DEVICES MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 158     EUROPE CONSUMABLES MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 159     EUROPE MASKS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 160     EUROPE RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 161     EUROPE OBSTRUCTIVE RESPIRATORY CONDITION MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 162     EUROPE COPD MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 163     EUROPE RESTRICTIVE RESPIRATORY CONDITION MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 164     EUROPE VASCULAR DISEASES MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 165     EUROPE INFECTIOUS RESPIRATORY CONDITIONS MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 166     EUROPE RESPIRATORY CARE DEVICE MARKET REVENUE, BASED ON END-USER, (2021-2029) ($MN)
      • TABLE 167     EUROPE HOSPITAL MARKET REVENUE, BASED ON CARE SETTINGS, (2021-2029) ($MN)
      • TABLE 168     EUROPE ERESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON COUNTRY, (2021-2029) ($MN)
      • TABLE 169     APAC RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 170     APAC THERAPEUTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 171     APAC HUMIDIFIERS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 172     APAC NEBULIZERS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 173     APAC OXYGEN CONCENTRATORS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 174     APAC POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 175     APAC RESUSCITATORS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 176     APAC VENTILATORS DEVICES MARKET REVENUE, BASED ON TYPE, (2021-2029) ($MN)
      • TABLE 177     APAC VENTILATORS MARKET REVENUE, BASED ON END-USER, (2021-2029) ($MN)
      • TABLE 178     APAC INHALERS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 179     APAC RESPIRATORY CARE MONITORING DEVICES MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 180     APAC PULSE OXIMETER MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 181     APAC DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BY PRODUCT, (2021-2029) ($MN)
      • TABLE 182     APAC SPIROMETERS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 183     APAC POLYSOMNOGRAPH DEVICES MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 184     APAC CONSUMABLES MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 185     APAC MASKS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 186     APAC RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 187     APAC OBSTRUCTIVE RESPIRATORY CONDITION MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 188     APAC COPD MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 189     APAC RESTRICTIVE RESPIRATORY CONDITION MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 190     APAC VASCULAR DISEASES MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 191     APAC INFECTIOUS RESPIRATORY MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 192     APAC RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON END-USER, (2021-2029) ($MN)
      • TABLE 193     APAC HOSPITAL MARKET REVENUE, BASED ON CARE SETTINGS, (2021-2029) ($MN)
      • TABLE 194     APAC RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON COUNTRY, (2021-2029) ($MN)
      • TABLE 195     ROW RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 196     ROW THERAPEUTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 197     ROW HUMIDIFIERS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 198     ROW NEBULIZERS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 199     ROW OXYGEN CONCENTRATORS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 200     ROW POSITIVE AIRWAY PRESSURE DEVICES (PAP) MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 201     ROW RESUSCITATORS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 202     ROW VENTILATORS DEVICES MARKET REVENUE, BASED ON TYPE, (2021-2029) ($MN)
      • TABLE 203     ROW VENTILATORS MARKET REVENUE, BASED ON END-USER, (2021-2029) ($MN)
      • TABLE 204     ROW INHALERS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 205     ROW MONITORING RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 206     ROW PULSE OXIMETER MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 207     ROW DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCT, (2021-2029) ($MN)
      • TABLE 208     ROW SPIROMETERS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 209     ROW POLYSOMNOGRAPH DEVICES MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 210     ROW CONSUMABLES MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 211     ROW MASKS MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 212     ROW RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 213     ROW OBSTRUCTIVE RESPIRATORY CONDITION MARKET REVENUE,BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 214     ROW COPD MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 215     ROW RESTRICTIVE RESPIRATORY CONDITION MARKET REVENUE, BASED ON APPLICATIONS, (2022 VS 2029) ($MN)
      • TABLE 216     ROW VASCULAR DISEASES MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 217     ROW INFECTIOUS RESPIRATORY MARKET REVENUE, BASED ON APPLICATIONS, (2021-2029) ($MN)
      • TABLE 218     ROW RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON END-USER, (2021-2029) ($MN)
      • TABLE 219     ROW HOSPITAL MARKET REVENUE, BASED ON CARE SETTINGS, (2021-2029) ($MN)
      • TABLE 220     ROW RESPIRATORY CARE DEVICE MARKET REVENUE, BASED ON COUNTRY, (2021-2029) ($MN)
      • TABLE 221     NEW PRODUCT LAUNCHES (2021-2023)
      • TABLE 222     APPROVALS (2021-2023)
      • TABLE 223     AGREEMENT (2021-2023)
      • TABLE 224     EXPANSION (2021-2023)
      • TABLE 225     AIR LIQUIDE S.A. : TOTAL REVENUE AND R&D EXPENSES, (2021-2022) ($MN)
      • TABLE 226     AIR LIQUIDE S.A.: TOTAL REVENUE, BY SEGMENT, (2021-2022) ($MN)
      • TABLE 227     DRAGERWERK AG & CO. KGAA TOTAL REVENUE AND R&D EXPENSES (2020 - 2022) ($MN)
      • TABLE 228     DRAGERWERK AG & CO. KGAA: TOTAL REVENUE, BY SEGMENTS, (2020 - 2022) ($MN)
      • TABLE 229     DRAGER MEDICAL AG & CO. KGAA: TOTAL REVENUE, BY GEOGRAPHY (2020 - 2022) ($MN)
      • TABLE 230     FISHER AND PAYKEL: TOTAL REVENUE AND R&D EXPENSES, (2020 -2022) ($MN)
      • TABLE 231     FISHER AND PAYKEL: TOTAL REVENUE, BY PRODUCTS, (2020 -2022) ($MN)
      • TABLE 232     FISHER AND PAYKEL TOTAL REVENUE, BY GEOGRAPHY, (2020 -2022) ($MN)
      • TABLE 233     INSPIRE MEDICAL SYSTEM, INC.: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) ($MN)
      • TABLE 234     INSPIRE MEDICAL SYSTEM,INC.: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) ($MN)
      • TABLE 235     GETINGE GROUPS: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) ($MN)
      • TABLE 236     GETINGE GROUPS: TOTAL REVENUE, BY SEGMENT, (2020-2022) ($MN)
      • TABLE 237     GETINGE GROUPS: TOTAL REVENUE, BY GEOGRAPHY, (2020-2022) ($MN)
      • TABLE 238     MASIMO CORPORATION : TOTAL REVENUE AND R&D EXPENSES, (2020-2022) ($MN)
      • TABLE 239     MASIMO CORPORATION: TOTAL REVENUE, BY SEGMENT (2020-2022) ($MN)
      • TABLE 240     MASIMO CORPORATION: TOTAL REVENUE, BY REGION, (2020-2022) ($MN)
      • TABLE 241     MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) ($MN)
      • TABLE 242     MEDTRONIC, PLC: TOTAL REVENUE, BASED ON SEGMENTS, (2020-2022) ($MN)
      • TABLE 243     MEDTRONIC, PLC: NEUROMODULATION TOTAL REVENUE, BASED ON SUB-SEGMENTS, (2022-2022)($MN)
      • TABLE 244     MEDTRONIC, PLC: TOTAL REVENUE, BASED ON GEOGRAPHY, (2021-2022) ($MN)
      • TABLE 245     PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES (2020-2022) ($MN)
      • TABLE 246     PHILIPS N.V.: TOTAL REVENUE, BY SEGMENTS (2020-2022) ($MN)
      • TABLE 247     PHILIPS N.V.: TOTAL REVENUE, BY GEOGRAPHY (2020-2022) ($MN)
      • TABLE 248     RESMED INC: TOTAL REVENUE AND R&D EXPENSES, (2021-2023) (Q3) ($MN)
      • TABLE 249     RESMED INC: TOTAL REVENUE, BY SEGMENT, (2021-2023) (Q3) ($MN)
      • TABLE 250     RESMED INC: TOTAL REVENUE, BY GEOGRAPHY, (2021-2023) (Q3) ($MN)

      LIST OF FIGURES

      • FIGURE 1     RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: RESPIRATORY CARE DEVICES GLOBAL MARKET
      • FIGURE 3     RESPIRATORY CARE DEVICES MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     RESPIRATORY CARE DEVICES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     RESPIRATORY CARE DEVICES GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
      • FIGURE 6     RESPIRATORY CARE DEVICES GLOBAL MARKET SEGMENTATION
      • FIGURE 7     RESPIRATORY CARE DEVICES GLOBAL MARKET SEGMENTATION
      • FIGURE 8     MARKET DYNAMICS
      • FIGURE 9     RESPIRATORY CARE DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 10     RESPIRATORY CARE DEVICE GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 11     RESPIRATORY CARE DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2022) (%)
      • FIGURE 12     VENTILATOR GLOBAL MARKET SHARE, BY KEY PLAYERS (2022) (%)
      • FIGURE 13     PAP DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS, (2022) (%)
      • FIGURE 14     CPAP DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS, (2022) (%)
      • FIGURE 15     APAP DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS, (2022) (%)
      • FIGURE 16     BPAP DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS, (2022) (%)
      • FIGURE 17     RESPIRATORY CARE DEVICES AND THERAPEUTIC DEVICES GLOBAL MARKET REVENUE, BASED ON PRODUCT, (2022), ($ MN))
      • FIGURE 18     HUMIDIFIERS GLOBAL MARKET SHARE, BASED ON PRODUCTS, (2022 V/S 2029), (%)
      • FIGURE 19     NEBULIZERS DEVICES GLOBAL MARKET SHARE, BASED ON REGION, (2022 V/S 2029), (%)
      • FIGURE 20     NEBULIZERS GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2022 V/S 2029), ($MN)
      • FIGURE 21     ULTRASONIC NEBULIZER GLOBAL MARKET SHARE, BASED ON REGION, (2022 V/S 2029), (%)
      • FIGURE 22     MESH NEBULIZER GLOBAL MARKET SHARE, BASED ON REGION, (2022 V/S 2029), (%)
      • FIGURE 23     OXYGEN CONCENTRATORS GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2022 VS 2029), ($MN)
      • FIGURE 24     POSITIVE AIRWAY PRESSURE (PAP) DEVICES GLOBAL MARKET SHARE, BASED ON PRODUCTS, (2022 VS 2029), (%)
      • FIGURE 25     RESUSCITATORS GLOBAL MARKET REVENUE, BASED ON PRODUCTS (2022 VS 2029) ($MN)
      • FIGURE 26     VENTILATORS GLOBAL MARKET REVENUE, BASED ON TYPE (2022 VS 2029) ($MN)
      • FIGURE 27     VENTILATORS GLOBAL MARKET SHARE, BASED ON END-USERS (2022 V/S 2029) (%)
      • FIGURE 28     EMERGENCY CARE VENTILATORS GLOBAL MARKET SHARE, BASED ON REGION (2022 V/S 2029) (%)
      • FIGURE 29     CRITICAL CARE VENTILATORS GLOBAL MARKET SHARE, BASED ON REGION (2022 V/S 2029) (%)
      • FIGURE 30     INHALERS GLOBAL MARKET REVENUE, BASED ON PRODUCTS (2022 V/S 2029) ($MN)
      • FIGURE 31     DRY POWDER INHALERS GLOBAL MARKET SHARE, BASED ON REGION (2022 V/S 2029) (%)
      • FIGURE 32     METERED DOSE INHALERS GLOBAL MARKET SHARE, BASED ON REGION (2022 V/S 2029) (%)
      • FIGURE 33     SOFT MIST INHALER DEVICES GLOBAL MARKET SHARE, BASED ON REGION (2022 V/S 2029) (%)
      • FIGURE 34     MONITORING RESPIRATORY CARE DEVICES AND PULSE OXIMETERS GLOBAL MARKET REVENUE, AND BASED ON PRODUCTS (2022) ($MN)
      • FIGURE 35     FINGER PULSE OXIMETERS GLOBAL MARKET SHARE, BASED ON REGION (2022 V/S 2029) (%)
      • FIGURE 36     TABLETOP PULSE OXIMETERS GLOBAL MARKET SHARE, BASED ON REGION (2022 V/S 2029) (%)
      • FIGURE 37     DIAGNOSTIC RESPIRATORY CARE DEVICES, SPIROMETERS AND POLYSOMNOGRAPH DEVICES GLOBAL MARKET SHARE, BASED ON PRODUCT, (2022), (%)
      • FIGURE 38     CONSUMABLES AND MASKS GLOBAL MARKET REVENUE, BASED ON PRODUCTS (2022) ($MN)
      • FIGURE 39     RESPIRATORY CARE DEVICES MARKET SHARE, BASED ON APPLCATIONS (2022 VS 2029) (%)
      • FIGURE 40     OBSTRUCTIVE RESPIRATORY CONDITION GLOBAL MARKET SHARE, BASED ON APPLICATIONS (2022 V/S 2029) (%)
      • FIGURE 41     COPD GLOBAL MARKET SHARE, BASED ON APPLICATION (2022 VS 2029) (%)
      • FIGURE 42     RESTRECTIVE RESPIRATORY CONDITION GLOBAL MARKET SHARE, BASED ON APPLICATIONS (2022 V/S 2029) (%)
      • FIGURE 43     VASCULAR DISEASES GLOBAL MARKET SHARE, BASED ON APPLICATIONS (2022 V/S 2029) (%)
      • FIGURE 44     INFECTIOUS RESPIRATORY CONDITION GLOBAL MARKET SHARE, BASED ON APPLICATIONS (2021 VS 2029) (%)
      • FIGURE 45     RESPIRATORY CARE DEVICE GLOBAL MARKET SHARE, BASED ON END-USER (2022 VS 2029) (%)
      • FIGURE 46     HOSPITAL GLOBAL MARKET SHARE, BASED ON CARE SETTINGS (2022 VS 2029) (%)
      • FIGURE 47     RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • FIGURE 48     RESPIRATORY CARE DEVICES GLOBAL MARKET REVENUE, BASED ON REGION AND COUNTRY (2022) ($MN)
      • FIGURE 49     NORTH AMERICA RESPIRATORY CARE DEVICES AND THERAPEUTIC DEVICES MARKET REVENUE, BASED ON PRODUCT (2022) ($ MN)
      • FIGURE 50     NORTH AMERICA HUMIDIFIERS MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 51     NORTH AMERICA NEBULIZERS MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 52     NORTH AMERICA OXYGEN CONCENTRATORS MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 53     NORTH AMERICA POSITIVE AIRWAY PRESSURE DEVICES MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 54     NORTH AMERICA RESUSCITATOR MARKET SHARE, BASED ON PRODUCTS (2022 V/S 2029) (%)
      • FIGURE 55     NORTH AMERICA VENTILATORS MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 56     NORTH AMERICA VENTILATORS MARKET SHARE, BASED ON END-USER (2022 VS 2029) (%)
      • FIGURE 57     NORTH AMERICA INHALERS MARKET SHARE, BASED ON PRODUCT (2022 V/S 2029) (%)
      • FIGURE 58     NORTH AMERICA RESPIRATORY CARE DEVICE MONITORING DEVICES AND PULSE OXIMETERS MARKET REVENUE, BASED ON PRODUCTS (2022) ($ MN)
      • FIGURE 59     NORTH AMERICA DIAGNOSTIC RESPIRATORY CARE DEVICES SPIROMETER, POLYSOMNOGRAPHS MARKET SHARE, BASED ON PRODUCT (2022) (%)
      • FIGURE 60     NORTH AMERICA CONSUMABLES AND MASKS MARKET REVENUE, BASED ON PRODUCT (2022) ($MN)
      • FIGURE 61     NORTH AMERICA RESPIRATORY CARE DEVICES MARKET SHARE, BASED ON APPLICATIONS (2022 V/S 2029) (%)
      • FIGURE 62     NORTH AMERICA OBSTRUCTIVE RESPIRATORY CONDITION MARKET SHARE, BASED ON APPLICATIONS (2022 VS 2029) (%)
      • FIGURE 63     NORTH AMERICA COPD MARKET SHARE, BASED ON APPLICATIONS (2022 VS 2029) (%)
      • FIGURE 64     NORTH AMERICA RESTRICTIVE RESPIRATORY CONDITION MARKET SHARE, BASED ON APPLICATIONS (2022 VS 2029) (%)
      • FIGURE 65     NORTH AMERICA VASCULAR DISEASES MARKET SHARE, BASED ON APPLICATIONS (2022 VS 2029) (%)
      • FIGURE 66     NORTH AMERICA INFECTIOUS RESPIRATORY CONDITIONS MARKET SHARE, BASED ON APPLICATIONS (2022 V/S 2029) (%)
      • FIGURE 67     NORTH AMERICA RESPIRATORY CARE DEVICES MARKET SHARE, BASED ON END-USER (2022 VS 2029) (%)
      • FIGURE 68     NORTH AMERICA HOSPITALS MARKET SHARE, BASED CARE SETTINGS (2022 V/S 2029) (%)
      • FIGURE 69     NORTH AMERICA RESPIRATORY CARE DEVICES MARKET SHARE, BASED ON COUNRY (2022 V/S 2029) (%)
      • FIGURE 70     U.S. RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, APPLICATION AND END -USERS (2022 V/S 2029) ($MN)
      • FIGURE 71     REST OF NORTH AMERICA RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, APPLICATION AND END - USERS (2022 V/S 2029) ($MN)
      • FIGURE 72     EUROPE RESPIRATORY CARE DEVICES AND THERAPEUTIC DEVICES MARKET REVENUE, BASED ON PRODUCTS (2022 V/S 2029) ($ MN)
      • FIGURE 73     EUROPE HUMIDIFIERS MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 74     EUROPE NEBULIZERS MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 75     EUROPE OXYGEN CONCENTRATORS MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 76     EUROPE POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 77     EUROPE RESUSCITATORS MARKET SHARE, BASED ON PRODUCTS (2022 V/S 2029) (%)
      • FIGURE 78     EUROPE VENTILATORS DEVICES MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 79     EUROPE VENTILATORS MARKET SHARE, BASED ON END-USERS (2022 VS 2029) (%)
      • FIGURE 80     EUROPE INHALERS MARKET SHARE, BASED ON PRODUCT (2022 V/S 2029) (%)
      • FIGURE 81     EUROPE MONITORING RESPIRATORY CARE DEVICES AND PULSE OXIMETERS MARKET REVENUE, BASED ON PRODUCTS (2022) ($ MN)
      • FIGURE 82     EUROPE DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET SHARE, (2022 V/S 2029) (%), SPIROMETER, POLYSOMNOGRAPHS MARKET REVENUE, BY PRODUCT (2022 V/S 2029) ($MN)
      • FIGURE 83     EUROPE CONSUMABLES AND MASKS MARKET REVENUE, BASED ON PRODUCTS (2022) ($MN)
      • FIGURE 84     EUROPE RESPIRATORY CARE DEVICES MARKET SHARE, BASED ON APPLICATIONS (2022 V/S 2029) (%)
      • FIGURE 85     EUROPE OBSTRUCTIVE RESPIRATORY CONDITION MARKET SHARE, BASED ON APPLICATIONS (2022 VS 2029) (%)
      • FIGURE 86     EUROPE COPD MARKET SHARE, BASED ON APPLICATIONS (2022 VS 2029) (%)
      • FIGURE 87     EUROPE RESTRICTIVE RESPIRATORY CONDITION MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 88     EUROPE VASCULAR DISEASES MARKET SHARE, BASED ON APPLICATIONS (2022 VS 2029) (%)
      • FIGURE 89     EUROPE INFECTIOUS RESPIRATORY CONDITIONS MARKET SHARE, BASED ON APPLICATIONS (2022 V/S 2029) (%)
      • FIGURE 90     EUROPE RESPIRATORY CARE DEVICE MARKET SHARE, BASED ON END-USER (2022 VS 2029) (%)
      • FIGURE 91     EUROPE RESPIRATORY CARE DEVICES MARKET SHARE, BASED ON CARE SETTINGS (2022 V/S 2029) ($MN)
      • FIGURE 92     EUROPE RESPIRATORY CARE DEVICES MARKET SHARE, BASED ON COUNRY (2022 V/S 2029) (%)
      • FIGURE 93     GERMANY RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, APPLICATION AND END – USERS (2022 V/S 2029) ($MN)
      • FIGURE 94     ITALY RESPIRATORY CARE DEVICES MARKET REVENUE, PRODUCTS, APPLICATION AND END – USERS (2022 V/S 2029) ($MN)
      • FIGURE 95     FRANCE RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS (2022 V/S 2029) ($MN)
      • FIGURE 96     REST OF EUROPE RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, APPLICATION AND END - USERS (2022 V/S 2029) ($MN)
      • FIGURE 97     APAC RESPIRATORY CARE DEVICES AND THERAPEUTIC DEVICES MARKET REVENUE, BASED ON PRODUCTS (2022) ($ MN)
      • FIGURE 98     APAC HUMIDIFIERS MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 99     APAC NEBULIZERS MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 100     APAC OXYGEN CONCENTRATORS MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 101     APAC POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 102     APAC RESUSCITATOR MARKET SHARE, BASED ON PRODUCTS (2022 V/S 2029) (%)
      • FIGURE 103     APAC VENTILATORS DEVICES MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 104     APAC VENTILATORS MARKET SHARE, BASED ON END-USERS (2022 V/S 2029) (%)
      • FIGURE 105     APAC INHALERS MARKET SHARE, BASED ON PRODUCT (2022 V/S 2029) (%)
      • FIGURE 106     APAC RESPIRATORY CARE MONITORING DEVICES AND PULSE OXIMETERS MARKET SHARE, BASED ON PRODUCTS (2022 V/S 2029) (%)
      • FIGURE 107     APAC DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET SHARE, (2022 V/S 2029) (%), SPIROMETER, POLYSOMNOGRAPHS MARKET REVENUE, BASED ON PRODUCT (2022 V/S 2029) ($MN)
      • FIGURE 108     APAC CONSUMABLES AND MASKS MARKET REVENUE, BASED ON PRODUCTS (2022) ($MN)
      • FIGURE 109     APAC RESPIRATORY CARE DEVICES MARKET SHARE, BASED ON APPLICATIONS (2022 V/S 2029) (%)
      • FIGURE 110     APAC OBSTRUCTIVE RESPIRATORY CONDITION MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 111     APAC COPD MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 112     APAC RESTRICTIVE RESPIRATORY CONDITION MARKET SHARE, BASED ON APPLICATION (2022 VS 2029) (%)
      • FIGURE 113     APAC VASCULAR DISEASES MARKET SHARE, BASED ON APPLICATIONS (2022 VS 2029) (%)
      • FIGURE 114     APAC INFECTIOUS RESPIRATORY CONDITIONS MARKET SHARE, BASED ON APPLICATIONS (2022 V/S 2029) (%)
      • FIGURE 115     APAC RESPIRATORY CARE DEVICES MARKET SHARE, BASED ON END-USER (2022 VS 2029) (%)
      • FIGURE 116     APAC HOSPITAL MARKET SHARE, BASED ON CARE SETTINGS (2022 V/S 2029) (%)
      • FIGURE 117     APAC RESPIRATORY CARE DEVICES MARKET SHARE, BASED ON COUNRY (2022 V/S 2029) (%)
      • FIGURE 118     JAPAN RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, APPLICATION AND END - USERS (2022 V/S 2029) ($MN)
      • FIGURE 119     CHINA RESPIRATORY CARE DEVICES MARKET REVENUE, PRODUCT, APPLICATIONS AND END – USERS (2022 VS 2029) ($MN)
      • FIGURE 120     INDIA RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, APPLICATION AND END - USERS (2022 V/S 2029) ($MN)
      • FIGURE 121     REST OF APAC RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, APPLICATION AND END -USERS (2022 V/S 2029) ($MN)
      • FIGURE 122     ROW RESPIRATORY CARE DEVICES AND THERAPEUTIC DEVICES MARKET REVENUE, BASED ON PRODUCTS (2022) ($ MN)
      • FIGURE 123     ROW HUMIDIFIERS MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 124     ROW NEBULIZERS MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 125     ROW OXYGEN CONCENTRATORS MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 126     ROW POSITIVE AIRWAY PRESSURE DEVICES MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 127     ROW RESUSCITATOR MARKET SHARE, BASED ON PRODUCTS (2022 V/S 2029) (%)
      • FIGURE 128     ROW VENTILATORS DEVICES MARKET SHARE, BASED ON PRODUCT (2022 VS 2029) (%)
      • FIGURE 129     ROW VENTILATORS MARKET SHARE, BASED ON END-USERS, (2022 V/S 2029) (%)
      • FIGURE 130     ROW INHALERS MARKET SHARE, BASED ON PRODUCT (2022 V/S 2029) (%)
      • FIGURE 131     ROW MONITORING RESPIRATORY CARE DEVICES AND PULSE OXIMETERS MARKET REVENUE, BASED ON PRODUCTS (2022) ($MN)
      • FIGURE 132     ROW RESPIRATORY CARE DIAGNOSTIC DEVICES, SPIROMETER, AND POLYSOMNOGRAPHS MARKET SHARE, BASED ON PRODUCT (2022) (%)
      • FIGURE 133     ROW CONSUMABLES AND MASKS MARKET REVENUE, BASED ON PRODUCTS (2022) ($MN)
      • FIGURE 134     ROW RESPIRATORY CARE DEVICES MARKET SHARE, BASED ON APPLICATIONS (2022 V/S 2029) (%)
      • FIGURE 135     ROW OBSTRUCTIVE RESPIRATORY CONDITION MARKET SHARE, BASED ON APPLICATION (2022 VS 2029) (%)
      • FIGURE 136     ROW COPD MARKET SHARE, BASED ON APPLICATIONS (2022 VS 2029) (%)
      • FIGURE 137     ROW RESTRICTIVE RESPIRATORY CONDITION MARKET SHARE, BASED ON APPLICATIONS (2022 VS 2029) (%)
      • FIGURE 138     ROW VASCULAR DISEASES MARKET SHARE, BASED ON APPLICATIONS (2022 VS 2029) (%)
      • FIGURE 139     ROW INFECTIOUS RESPIRATORY CONDITIONS MARKET SHARE, BASED ON APPLICATIONS (2022 V/S 2029) (%)
      • FIGURE 140     ROW RESPIRATORY CARE DEVICES MARKET SHARE, BASED ON END-USER (2022 VS 2029) (%)
      • FIGURE 141     ROW RESPIRATORY CARE DEVICE MARKET SHARE, BASED ON CARE SETTINGS (2022 V/S 2029) (%)
      • FIGURE 142     ROW RESPIRATORY CARE DEVICES MARKET SHARE, BASED ON COUNRY (2022 V/S 2029) (%)
      • FIGURE 143     BRAZIL RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, APPLICATIONS AND END - USERS (2022 V/S 2029) ($MN)
      • FIGURE 144     REST OF LATAM RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, APPLICATIONS AND END - USERS (2022 V/S 2029) ($MN)
      • FIGURE 145     MIDDLE EAST & OTHERS RESPIRATORY CARE DEVICES MARKET REVENUE, BASED ON PRODUCTS, APPLICATION AND END - USERS (2022 V/S 2029) ($MN)
      • FIGURE 146     KEY GROWTH STRATEGIES, (2021 – 2023)
      • FIGURE 147     SWOT: AIR LIQUIDE S.A.
      • FIGURE 148     SWOT: DRAGERWERK AG & CO. KGAA
      • FIGURE 149     SWOT: FISHER AND PAYKEL HEALTHCARE CORPORATION LIMITED
      • FIGURE 150     SWOT: INSPIRE MEDICAL SYSTEM, INC.
      • FIGURE 151     SWOT: GETINGE GROUP
      • FIGURE 152     SWOT: MASIMO CORP.
      • FIGURE 153     SWOT: MEDTRONIC
      • FIGURE 154     SWOT: PHILIPS N.V.
      • FIGURE 155     SWOT: RESMED INC.
      • FIGURE 156     SWOT: VYAIRE MEDICAL INC

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     AB Industries ( Max Ventilator)
      • 2     ABM Respiratory Care
      • 3     Acare Technology Co., Ltd.
      • 4     Acurable
      • 5     Aevice Health
      • 6     Air Liquide Medical Systems SA
      • 7     Airon Corporation
      • 8     ALBEDO Medical Devices Co.,Ltd.
      • 9     Ambu A/S
      • 10     Avanos Medical
      • 11     Baxter International INC (Hillrom)
      • 12     Besco Medical Co.Ltd.
      • 13     Besmed Health Business Corp.
      • 14     Bio-Med Devices, Inc.
      • 15     Bird Healthcare
      • 16     BPL medical technologies
      • 17     Breas Medical
      • 18     Bunnell Inc.
      • 19     Caire Inc.
      • 20     Carl Reiner GmbH
      • 21     ChoiceMMed (Beijing Choice Electronic Technology Co., Ltd)
      • 22     CIDELEC
      • 23     Mindray
      • 24     Monaghan Medical Corporation
      • 25     Movair
      • 26     ndd Medical Technologies
      • 27     Neola Medical
      • 28     nice Neotech Medical Systems Private Limited
      • 29     Nihon Kohden Corporation
      • 30     Nonin Medical Inc
      • 31     Nonin Medical, Inc
      • 32     Nox Medical
      • 33     O2 concepts. LLC
      • 34     Omron Healthcare
      • 35     O-Two Medical Technologies Inc.
      • 36     Oxitone Medical Ltd
      • 37     Cleveland Medical Devices Inc.
      • 38     Compumedics
      • 39     Contec Medical Systems Co.,Ltd
      • 40     Cosmed srl
      • 41     Deas S.R.L.
      • 42     DeyMed Diagnostic s.r.o (Czech Republic)
      • 43     Diamedica Limited
      • 44     DR Burton Healthcare LLC
      • 45     Drägerwerk AG & Co. KGaA
      • 46     Drive Medical (Devilbiss Healthcare)
      • 47     dymedso inc
      • 48     ESAB Corporation (GCE Healthcare)
      • 49     FANEM Ltda
      • 50     Fisher and Paykel healthcare
      • 51     Flexicare Medical Limited
      • 52     Flight-Medical Innovations Ltd.
      • 53     Galemed Corporation
      • 54     GE Healthcare
      • 55     Geratherm Respiratory GmbH
      • 56     Gerresheimer
      • 57     Getinge Groups
      • 58     Hamilton Medical AG
      • 59     PARI Medical Holding GmbH
      • 60     Philips N.V.
      • 61     Precision Medical Inc
      • 62     Pulmodyne, Inc
      • 63     React Health
      • 64     Recipharm
      • 65     Resmed, Inc
      • 66     Senzime (Respiratory Motion Inc)
      • 67     Servona GmbH
      • 68     Shenyang Canta Medical Tech. Co., Ltd.
      • 69     Shenzhen Homed Medical Device Co.Ltd.
      • 70     Strados Labs
      • 71     Hans Rudolph, Inc
      • 72     Hayek Industries Inc
      • 73     Heyer medical AG
      • 74     Hospitech respiration
      • 75     Iconovo
      • 76     ICUmedical (Smith medical)
      • 77     Inspiration Healthcare Group PLC
      • 78     Inspired Medical
      • 79     Intersurgical Ltd
      • 80     Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
      • 81     Lowenstein Medical
      • 82     Masimo corporation
      • 83     Medel International srl
      • 84     Medical Developments International UK Limited
      • 85     Medical Econet GmbH
      • 86     medin Medical Innovations GmbH
      • 87     MediPines Corporation
      • 88     Medtronic, PLC
      • 89     MEK-ICS Co Ltd
      • 90     Mercury medical
      • 91     Merxin Ltd
      • 92     MicroBase Technology Corporation
      • 93     Sibelmed
      • 94     SOMNOmedics GmbH
      • 95     SunMed, LLC
      • 96     Sunset Healthcare Solutions Inc.
      • 97     Tecme S.A.
      • 98     Trudell Medical
      • 99     Vapotherm Inc.
      • 100     Vitalograph, Inc
      • 101     Vyaire Medical Inc.
      • 102     WILAmed GmbH